These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19595063)

  • 1. [Effects and toxicity of neoadjuvant chemotherapy with vinorelbine and cisplatin in treatment of operable breast cancer previously non-responsive to anthracyclines and taxanes-containing regimen: analysis of 19 cases].
    Xu L; Ye JM; Zhao JX; Duan XN; Liu YH
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):683-5. PubMed ID: 19595063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of vinorelbine plus cisplatin as second-line neoadjuvant chemotherapy regimen in the treatment of breast cancer].
    Wang J; Xu L; Ye JM; Zhao JX; Duan XN; Liu YH
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):93-5. PubMed ID: 23648342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.
    Halim A; Wahba H
    Med Oncol; 2012 Jun; 29(2):454-8. PubMed ID: 21350875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines.
    Vassilomanolakis M; Koumakis G; Barbounis V; Demiri M; Pateras H; Efremidis AP
    Ann Oncol; 2000 Sep; 11(9):1155-60. PubMed ID: 11061611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
    Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes.
    Wang J; Zheng R; Wang Z; Yang Y; Wang M; Zou W
    Med Sci Monit; 2017 Sep; 23():4657-4664. PubMed ID: 28957036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer].
    Chen CM; Shen KW; Liu GY; Wu J; Lu JS; Zhuang CJ; Han QX; Liu BL; Shao ZM; Shen ZZ
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):745-7. PubMed ID: 16836921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Fan Y; Xu B; Yuan P; Wang J; Ma F; Li Q; Zhang P; Li Q; Cai R
    Chemotherapy; 2010; 56(4):340-7. PubMed ID: 20720418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and toxicity of vinorelbine (NVB)-based regimens in patients with metastatic triple negative breast cancer (mTNBC) pretreated with anthracyclines and taxanes].
    Du F; Yuan P; Luo Y; Wang J; Ma F; Cai R; Fan Y; Li Q; Zhang P; Xu B
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):788-92. PubMed ID: 26813602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer.
    Shamseddine AI; Taher A; Dabaja B; Dandashi A; Salem Z; El Saghir NS
    Am J Clin Oncol; 1999 Jun; 22(3):298-302. PubMed ID: 10362341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
    Orlando L; Colleoni M; Curigliano G; Nolè F; Ferretti G; Masci G; Peruzzotti G; Minchella I; Intra M; Veronesi P; Viale G; Goldhirsch A
    Anticancer Res; 2001; 21(6A):4135-9. PubMed ID: 11911307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.
    Antón A; Barnadas A; Florián J; Ribelles N; Lomas M; Lao J; González-Quintás A; Margelí M; Paules AB; Gayo J; Ramos M;
    Clin Transl Oncol; 2011 Apr; 13(4):281-6. PubMed ID: 21493190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes.
    Toi M; Saeki T; Aogi K; Sano M; Hatake K; Asaga T; Tokuda Y; Mitsuyama S; Kimura M; Kobayashi T; Tamura M; Tabei T; Shin E; Nishimura R; Ohno S; Takashima S
    Jpn J Clin Oncol; 2005 Jun; 35(6):310-5. PubMed ID: 15930037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine in breast cancer.
    Bonneterre J; Penel N
    Expert Opin Pharmacother; 2008 Nov; 9(16):2901-10. PubMed ID: 18937621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Estévez LG; Batista N; Sánchez-Rovira P; Velasco A; Provencio M; León A; Dómine M; Cruz J; Rodríguez M
    Clin Breast Cancer; 2008 Apr; 8(2):149-54. PubMed ID: 18621611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial.
    Gao LL; Huang XE; Zhang Q; Tang JH
    Asian Pac J Cancer Prev; 2011; 12(1):77-80. PubMed ID: 21517235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment.
    Li M; Fan Y; Li Q; Zhang P; Yuan P; Ma F; Wang J; Luo Y; Cai R; Chen S; Li Q; Xu B
    Medicine (Baltimore); 2015 Oct; 94(43):e1928. PubMed ID: 26512619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin plus vinorelbine as a salvage regimen in refractory breast cancer.
    Günel N; Akçali Z; Yamaç D; Onuk E; Yilmaz E; Bayram O; Tekin E; Coşkun U
    Tumori; 2000; 86(4):283-5. PubMed ID: 11016704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.
    Farhat FS; Temraz S; Kattan J; Ibrahim K; Bitar N; Haddad N; Jalloul R; Hatoum HA; Nsouli G; Shamseddine AI
    Clin Breast Cancer; 2011 Dec; 11(6):384-9. PubMed ID: 21993011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.